Recent advances in cardiovascular stent for treatment of in-stent restenosis: Mechanisms and strategies

Yao, Hang; He, Yuwei; Ma, Jinrong; Jiang, Lang; Li, Jingan; Wang, Jin; Huang, Nan

doi:10.1016/j.cjche.2020.11.025

Cited by 11 publications

(1 citation statement)

References 164 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[201] The dysfunctional ECs produce thrombogenic factors and release pro-inflammatory signal molecules, thus increasing thrombogenic risks and exacerbating IH. [7,202] As a result, the application of DESs is substantially hindered by serious EC dysfunction. A large number of practices have indicated that anti-coagulant and anti-proliferative therapies based on EC-toxic drugs cannot yield satisfactory therapeutic efficacy.…”

Section: Vascular Restenosismentioning

confidence: 99%

Recent Advances in Cell‐Based Nanotherapy for Cardiovascular Diseases

Hao

2023

Macromolecular Bioscience

View full text Add to dashboard Cite

Cell‐based nanotherapy holds great potential to transform diagnosis and treatment patterns for human diseases, especially for cardiovascular diseases (CVDs). Surface coating with cell membrane has become a powerful strategy for functionalization of therapeutic nanoparticles to achieve biological performances of superior biocompatibility, immune evasion, and specificity. Additionally, extracellular vesicles (EVs) play key roles in the progression of CVDs with their ability of transferring cargos to distant tissues, thus emerging as an appealing option for the diagnosis and therapy of CVDs. In this review, recent progress in cell‐based nanotherapy for CVDs is summarized, and different sources of EVs and biomimetic nanoplatforms derived from natural cells are highlighted. Meanwhile, their promising biomedical applications in the diagnosis and targeted treatment of different CVDs are also provided, followed by a discussion of their potential challenges and future prospects.

show abstract

Section: Vascular Restenosismentioning

confidence: 99%

Recent Advances in Cell‐Based Nanotherapy for Cardiovascular Diseases

Hao

2023

Macromolecular Bioscience

View full text Add to dashboard Cite

show abstract

Development of Innovative Biomaterials and Devices for the Treatment of Cardiovascular Diseases

Wang

Yang

et al. 2022

Advanced Materials

View full text Add to dashboard Cite

Cardiovascular diseases have become the leading cause of death worldwide. The increasing burden of cardiovascular diseases has become a major public health problem and how to carry out efficient and reliable treatment of cardiovascular diseases has become an urgent global problem to be solved. Recently, implantable biomaterials and devices, especially minimally invasive interventional ones, such as vascular stents, artificial heart valves, bioprosthetic cardiac occluders, artificial graft cardiac patches, atrial shunts, and injectable hydrogels against heart failure, have become the most effective means in the treatment of cardiovascular diseases. Herein, an overview of the challenges and research frontier of innovative biomaterials and devices for the treatment of cardiovascular diseases is provided, and their future development directions are discussed.

show abstract

3D-printed bioresorbable vascular stents: emerging frontiers in personalized cardiac care

Gautam,

Wairkar

2024

Polym. Bull.

View full text Add to dashboard Cite

Recent advances in cardiovascular stent for treatment of in-stent restenosis: Mechanisms and strategies

Cited by 11 publications

References 164 publications

Recent Advances in Cell‐Based Nanotherapy for Cardiovascular Diseases

Recent Advances in Cell‐Based Nanotherapy for Cardiovascular Diseases

Development of Innovative Biomaterials and Devices for the Treatment of Cardiovascular Diseases

3D-printed bioresorbable vascular stents: emerging frontiers in personalized cardiac care

Contact Info

Product

Resources

About